drugset / Trial / NCT00698282

Single and Multiple Ascending Doses of AZD1981 in Japan

NCT00698282

Phase 1 Completed 47 enrolled AstraZeneca
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to study safety, tolerability and pharmacokinetics of AZD1981 in healthy Japanese subjects

Timeline

Start
2008-08
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1981 Small molecule 15 mg Oral
Subject AZD1981 Small molecule 75 mg Oral
Subject AZD1981 Small molecule 250 mg Oral
Subject AZD1981 Small molecule 1000 mg Oral
Subject AZD1981 Small molecule 2000 mg Oral

Indications

No indication recorded.